Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 77 entries
Sorted by: Best Match Show Resources per page
Discussing current syphilis case definitions: A proposal for a "probable infectious" case.

Public health nursing (Boston, Mass.)

O'Byrne P, Orser L, MacPherson P.
PMID: 33249649
Public Health Nurs. 2021 May;38(3):390-395. doi: 10.1111/phn.12850. Epub 2020 Nov 29.

Syphilis has increased in recent years, causing difficulties for clinicians and public health practitioners alike. While one issue with the current management of syphilis is that it has both a myriad of presentations and complicated laboratory results, another issue...

Cite
O'Byrne P, Orser L, MacPherson P. Discussing current syphilis case definitions: A proposal for a "probable infectious" case. Public Health Nurs. 2020;38(3):390-395doi: 10.1111/phn.12850.
O'Byrne, P., Orser, L., & MacPherson, P. (2021). Discussing current syphilis case definitions: A proposal for a "probable infectious" case. Public health nursing (Boston, Mass.), 38(3), 390-395. https://doi.org/10.1111/phn.12850
O'Byrne, Patrick, et al. "Discussing current syphilis case definitions: A proposal for a "probable infectious" case." Public health nursing (Boston, Mass.) vol. 38,3 (2021): 390-395. doi: https://doi.org/10.1111/phn.12850
O'Byrne P, Orser L, MacPherson P. Discussing current syphilis case definitions: A proposal for a "probable infectious" case. Public Health Nurs. 2021 May;38(3):390-395. doi: 10.1111/phn.12850. Epub 2020 Nov 29. PMID: 33249649.
Copy Download .nbib Format: NLM
Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic.

European journal of preventive cardiology

Banerjee A, Chen S, Pasea L, Lai AG, Katsoulis M, Denaxas S, Nafilyan V, Williams B, Wong WK, Bakhai A, Khunti K, Pillay D, Noursadeghi M, Wu H, Pareek N, Bromage D, McDonagh TA, Byrne J, Teo JTH, Shah AM, Humberstone B, Tang LV, Shah ASV, Rubboli A, Guo Y, Hu Y, Sudlow CLM, Lip GYH, Hemingway H.
PMID: 33611594
Eur J Prev Cardiol. 2021 Dec 20;28(14):1599-1609. doi: 10.1093/eurjpc/zwaa155.

AIMS: Cardiovascular diseases (CVDs) increase mortality risk from coronavirus infection (COVID-19). There are also concerns that the pandemic has affected supply and demand of acute cardiovascular care. We estimated excess mortality in specific CVDs, both 'direct', through infection, and...

Cite
Banerjee A, Chen S, Pasea L, et al. Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic. Eur J Prev Cardiol. 2021;28(14):1599-1609doi: 10.1093/eurjpc/zwaa155.
Banerjee, A., Chen, S., Pasea, L., Lai, A. G., Katsoulis, M., Denaxas, S., Nafilyan, V., Williams, B., Wong, W. K., Bakhai, A., Khunti, K., Pillay, D., Noursadeghi, M., Wu, H., Pareek, N., Bromage, D., McDonagh, T. A., Byrne, J., Teo, J. T. H., Shah, A. M., Humberstone, B., Tang, L. V., Shah, A. S. V., Rubboli, A., Guo, Y., Hu, Y., Sudlow, C. L. M., Lip, G. Y. H., & Hemingway, H. (2021). Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic. European journal of preventive cardiology, 28(14), 1599-1609. https://doi.org/10.1093/eurjpc/zwaa155
Banerjee, Amitava, et al. "Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic." European journal of preventive cardiology vol. 28,14 (2021): 1599-1609. doi: https://doi.org/10.1093/eurjpc/zwaa155
Banerjee A, Chen S, Pasea L, Lai AG, Katsoulis M, Denaxas S, Nafilyan V, Williams B, Wong WK, Bakhai A, Khunti K, Pillay D, Noursadeghi M, Wu H, Pareek N, Bromage D, McDonagh TA, Byrne J, Teo JTH, Shah AM, Humberstone B, Tang LV, Shah ASV, Rubboli A, Guo Y, Hu Y, Sudlow CLM, Lip GYH, Hemingway H. Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic. Eur J Prev Cardiol. 2021 Dec 20;28(14):1599-1609. doi: 10.1093/eurjpc/zwaa155. PMID: 33611594; PMCID: PMC7928969.
Copy Download .nbib Format: NLM
Management of post-cervical laminectomy fusion pain syndrome with a successful trial of spinal cord stimulation.

Pain reports

Dahbour L, Wright TB, Rusha L, Uppal P, Gattu K, Lee SJ, Watterworth B, Stansbury L.
PMID: 34963997
Pain Rep. 2021 Dec 21;6(4):e981. doi: 10.1097/PR9.0000000000000981. eCollection 2021.

INTRODUCTION: Spinal cord stimulation has been shown to be beneficial in various postsurgical neuropathic pain syndromes, but the already small cervical epidural space due to epidural fibrosis makes cervical spinal cord stimulator placement very difficult. We present a case...

Cite
Dahbour L, Wright TB, Rusha L, et al. Management of post-cervical laminectomy fusion pain syndrome with a successful trial of spinal cord stimulation. Pain Rep. 2021;6(4):e981doi: 10.1097/PR9.0000000000000981.
Dahbour, L., Wright, T. B., Rusha, L., Uppal, P., Gattu, K., Lee, S. J., Watterworth, B., & Stansbury, L. (2021). Management of post-cervical laminectomy fusion pain syndrome with a successful trial of spinal cord stimulation. Pain reports, 6(4), e981. https://doi.org/10.1097/PR9.0000000000000981
Dahbour, Layth, et al. "Management of post-cervical laminectomy fusion pain syndrome with a successful trial of spinal cord stimulation." Pain reports vol. 6,4 (2021): e981. doi: https://doi.org/10.1097/PR9.0000000000000981
Dahbour L, Wright TB, Rusha L, Uppal P, Gattu K, Lee SJ, Watterworth B, Stansbury L. Management of post-cervical laminectomy fusion pain syndrome with a successful trial of spinal cord stimulation. Pain Rep. 2021 Dec 21;6(4):e981. doi: 10.1097/PR9.0000000000000981. eCollection 2021. PMID: 34963997; PMCID: PMC8702275.
Copy Download .nbib Format: NLM
Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy.

mBio

Gálvez C, Grau-Expósito J, Urrea V, Clotet B, Falcó V, Buzón MJ, Martinez-Picado J.
PMID: 34844430
mBio. 2021 Nov 30;e0307821. doi: 10.1128/mBio.03078-21. Epub 2021 Nov 30.

Knowing the mechanisms that govern the persistence of infected CD4

Cite
Gálvez C, Grau-Expósito J, Urrea V, et al. Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy. mBio. 2021;e0307821doi: 10.1128/mBio.03078-21.
Gálvez, C., Grau-Expósito, J., Urrea, V., Clotet, B., Falcó, V., Buzón, M. J., & Martinez-Picado, J. (2021). Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy. mBio, e0307821. https://doi.org/10.1128/mBio.03078-21
Gálvez, Cristina, et al. "Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy." mBio vol. (2021): e0307821. doi: https://doi.org/10.1128/mBio.03078-21
Gálvez C, Grau-Expósito J, Urrea V, Clotet B, Falcó V, Buzón MJ, Martinez-Picado J. Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy. mBio. 2021 Nov 30;e0307821. doi: 10.1128/mBio.03078-21. Epub 2021 Nov 30. PMID: 34844430; PMCID: PMC8630536.
Copy Download .nbib Format: NLM
Sex Differences in BNST and Amygdala Activation by Contextual, Cued, and Unpredictable Threats.

eNeuro

Urien L, Bauer EP.
PMID: 34911788
eNeuro. 2022 Jan 06;9(1). doi: 10.1523/ENEURO.0233-21.2021. Print 2022.

Fear and anxiety can be described as emotional and physical responses to predictable and unpredictable threats. While the amygdala is necessary for context and cued fear conditioning, the bed nucleus of the stria terminalis (BNST) is important for anxiety-like...

Cite
Urien L, Bauer EP. Sex Differences in BNST and Amygdala Activation by Contextual, Cued, and Unpredictable Threats. eNeuro. 2022;9(1)doi: 10.1523/ENEURO.0233-21.2021.
Urien, L., & Bauer, E. P. (2022). Sex Differences in BNST and Amygdala Activation by Contextual, Cued, and Unpredictable Threats. eNeuro, 9(1), . https://doi.org/10.1523/ENEURO.0233-21.2021
Urien, Louise, and Bauer, Elizabeth P. "Sex Differences in BNST and Amygdala Activation by Contextual, Cued, and Unpredictable Threats." eNeuro vol. 9,1 (2022). doi: https://doi.org/10.1523/ENEURO.0233-21.2021
Urien L, Bauer EP. Sex Differences in BNST and Amygdala Activation by Contextual, Cued, and Unpredictable Threats. eNeuro. 2022 Jan 06;9(1). doi: 10.1523/ENEURO.0233-21.2021. Print 2022. PMID: 34911788; PMCID: PMC8741146.
Copy Download .nbib Format: NLM
'What is the risk to me from COVID-19?': Public involvement in providing mortality risk information for people with 'high-risk' conditions for COVID-19 (OurRisk.CoV).

Clinical medicine (London, England)

Banerjee A, Pasea L, Manohar S, Lai AG, Hemingway E, Sofer I, Katsoulis M, Sood H, Morris A, Cake C, Fitzpatrick NK, Williams B, Denaxas S, Hemingway H.
PMID: 34862222
Clin Med (Lond). 2021 Nov;21(6):e620-e628. doi: 10.7861/clinmed.2021-0386.

Patients and public have sought mortality risk information throughout the pandemic, but their needs may not be served by current risk prediction tools. Our mixed methods study involved: (1) systematic review of published risk tools for prognosis, (2) provision...

Cite
Banerjee A, Pasea L, Manohar S, et al. 'What is the risk to me from COVID-19?': Public involvement in providing mortality risk information for people with 'high-risk' conditions for COVID-19 (OurRisk.CoV). Clin Med (Lond). 2021;21(6):e620-e628doi: 10.7861/clinmed.2021-0386.
Banerjee, A., Pasea, L., Manohar, S., Lai, A. G., Hemingway, E., Sofer, I., Katsoulis, M., Sood, H., Morris, A., Cake, C., Fitzpatrick, N. K., Williams, B., Denaxas, S., Hemingway, H. (2021). 'What is the risk to me from COVID-19?': Public involvement in providing mortality risk information for people with 'high-risk' conditions for COVID-19 (OurRisk.CoV). Clinical medicine (London, England), 21(6), e620-e628. https://doi.org/10.7861/clinmed.2021-0386
Banerjee, Amitava, et al. "'What is the risk to me from COVID-19?': Public involvement in providing mortality risk information for people with 'high-risk' conditions for COVID-19 (OurRisk.CoV)." Clinical medicine (London, England) vol. 21,6 (2021): e620-e628. doi: https://doi.org/10.7861/clinmed.2021-0386
Banerjee A, Pasea L, Manohar S, Lai AG, Hemingway E, Sofer I, Katsoulis M, Sood H, Morris A, Cake C, Fitzpatrick NK, Williams B, Denaxas S, Hemingway H. 'What is the risk to me from COVID-19?': Public involvement in providing mortality risk information for people with 'high-risk' conditions for COVID-19 (OurRisk.CoV). Clin Med (Lond). 2021 Nov;21(6):e620-e628. doi: 10.7861/clinmed.2021-0386. PMID: 34862222.
Copy Download .nbib Format: NLM
'What is the risk to me from COVID-19?': Public involvement in providing mortality risk information for people with 'high-risk' conditions for COVID-19 (OurRisk.CoV).

Clinical medicine (London, England)

Banerjee A, Pasea L, Manohar S, Lai AG, Hemingway E, Sofer I, Katsoulis M, Sood H, Morris A, Cake C, Fitzpatrick NK, Williams B, Denaxas S, Hemingway H.
PMID: 34862222
Clin Med (Lond). 2021 Nov;21(6):e620-e628. doi: 10.7861/clinmed.2021-0386.

Patients and public have sought mortality risk information throughout the pandemic, but their needs may not be served by current risk prediction tools. Our mixed methods study involved: (1) systematic review of published risk tools for prognosis, (2) provision...

Cite
Banerjee A, Pasea L, Manohar S, et al. 'What is the risk to me from COVID-19?': Public involvement in providing mortality risk information for people with 'high-risk' conditions for COVID-19 (OurRisk.CoV). Clin Med (Lond). 2021;21(6):e620-e628doi: 10.7861/clinmed.2021-0386.
Banerjee, A., Pasea, L., Manohar, S., Lai, A. G., Hemingway, E., Sofer, I., Katsoulis, M., Sood, H., Morris, A., Cake, C., Fitzpatrick, N. K., Williams, B., Denaxas, S., Hemingway, H. (2021). 'What is the risk to me from COVID-19?': Public involvement in providing mortality risk information for people with 'high-risk' conditions for COVID-19 (OurRisk.CoV). Clinical medicine (London, England), 21(6), e620-e628. https://doi.org/10.7861/clinmed.2021-0386
Banerjee, Amitava, et al. "'What is the risk to me from COVID-19?': Public involvement in providing mortality risk information for people with 'high-risk' conditions for COVID-19 (OurRisk.CoV)." Clinical medicine (London, England) vol. 21,6 (2021): e620-e628. doi: https://doi.org/10.7861/clinmed.2021-0386
Banerjee A, Pasea L, Manohar S, Lai AG, Hemingway E, Sofer I, Katsoulis M, Sood H, Morris A, Cake C, Fitzpatrick NK, Williams B, Denaxas S, Hemingway H. 'What is the risk to me from COVID-19?': Public involvement in providing mortality risk information for people with 'high-risk' conditions for COVID-19 (OurRisk.CoV). Clin Med (Lond). 2021 Nov;21(6):e620-e628. doi: 10.7861/clinmed.2021-0386. PMID: 34862222.
Copy Download .nbib Format: NLM
Determination of Phenolics and Flavonoids of Some Useful Medicinal Plants and Bioassay-Guided Fractionation Substances of .

Frontiers in chemistry

Abdallah MS, Mustafa M, Nallappan MA, Choi S, Paik JH, Rusea G.
PMID: 34386478
Front Chem. 2021 Jul 27;9:670530. doi: 10.3389/fchem.2021.670530. eCollection 2021.

Gallic acid and catechin are the most abundant phenolic and flavonoid contents found in all plant extracts. The contents and the bioassay-guided fractionating substances of the

Cite
Abdallah MS, Mustafa M, Nallappan MA, et al. Determination of Phenolics and Flavonoids of Some Useful Medicinal Plants and Bioassay-Guided Fractionation Substances of . Front Chem. 2021;9:670530doi: 10.3389/fchem.2021.670530.
Abdallah, M. S., Mustafa, M., Nallappan, M. A., Choi, S., Paik, J. H., & Rusea, G. (2021). Determination of Phenolics and Flavonoids of Some Useful Medicinal Plants and Bioassay-Guided Fractionation Substances of . Frontiers in chemistry, 9670530. https://doi.org/10.3389/fchem.2021.670530
Abdallah, Muhammad Salihu, et al. "Determination of Phenolics and Flavonoids of Some Useful Medicinal Plants and Bioassay-Guided Fractionation Substances of ." Frontiers in chemistry vol. 9 (2021): 670530. doi: https://doi.org/10.3389/fchem.2021.670530
Abdallah MS, Mustafa M, Nallappan MA, Choi S, Paik JH, Rusea G. Determination of Phenolics and Flavonoids of Some Useful Medicinal Plants and Bioassay-Guided Fractionation Substances of . Front Chem. 2021 Jul 27;9:670530. doi: 10.3389/fchem.2021.670530. eCollection 2021. PMID: 34386478; PMCID: PMC8353516.
Copy Download .nbib Format: NLM
Remote Actuation Systems for Fully Wearable Assistive Devices: Requirements, Selection, and Optimization for Out-of-the-Lab Application of a Hand Exoskeleton.

Frontiers in robotics and AI

Dittli J, Hofmann UAT, Bützer T, Smit G, Lambercy O, Gassert R.
PMID: 33585573
Front Robot AI. 2021 Jan 28;7:596185. doi: 10.3389/frobt.2020.596185. eCollection 2020.

Wearable robots assist individuals with sensorimotor impairment in daily life, or support industrial workers in physically demanding tasks. In such scenarios, low mass and compact design are crucial factors for device acceptance. Remote actuation systems (RAS) have emerged as...

Cite
Dittli J, Hofmann UAT, Bützer T, et al. Remote Actuation Systems for Fully Wearable Assistive Devices: Requirements, Selection, and Optimization for Out-of-the-Lab Application of a Hand Exoskeleton. Front Robot AI. 2021;7:596185doi: 10.3389/frobt.2020.596185.
Dittli, J., Hofmann, U. A. T., Bützer, T., Smit, G., Lambercy, O., & Gassert, R. (2020). Remote Actuation Systems for Fully Wearable Assistive Devices: Requirements, Selection, and Optimization for Out-of-the-Lab Application of a Hand Exoskeleton. Frontiers in robotics and AI, 7596185. https://doi.org/10.3389/frobt.2020.596185
Dittli, Jan, et al. "Remote Actuation Systems for Fully Wearable Assistive Devices: Requirements, Selection, and Optimization for Out-of-the-Lab Application of a Hand Exoskeleton." Frontiers in robotics and AI vol. 7 (2020): 596185. doi: https://doi.org/10.3389/frobt.2020.596185
Dittli J, Hofmann UAT, Bützer T, Smit G, Lambercy O, Gassert R. Remote Actuation Systems for Fully Wearable Assistive Devices: Requirements, Selection, and Optimization for Out-of-the-Lab Application of a Hand Exoskeleton. Front Robot AI. 2021 Jan 28;7:596185. doi: 10.3389/frobt.2020.596185. eCollection 2020. PMID: 33585573; PMCID: PMC7876397.
Copy Download .nbib Format: NLM
Sex Differences in BNST and Amygdala Activation by Contextual, Cued, and Unpredictable Threats.

eNeuro

Urien L, Bauer EP.
PMID: 34911788
eNeuro. 2022 Jan 06;9(1). doi: 10.1523/ENEURO.0233-21.2021. Print 2022.

Fear and anxiety can be described as emotional and physical responses to predictable and unpredictable threats. While the amygdala is necessary for context and cued fear conditioning, the bed nucleus of the stria terminalis (BNST) is important for anxiety-like...

Cite
Urien L, Bauer EP. Sex Differences in BNST and Amygdala Activation by Contextual, Cued, and Unpredictable Threats. eNeuro. 2022;9(1)doi: 10.1523/ENEURO.0233-21.2021.
Urien, L., & Bauer, E. P. (2022). Sex Differences in BNST and Amygdala Activation by Contextual, Cued, and Unpredictable Threats. eNeuro, 9(1), . https://doi.org/10.1523/ENEURO.0233-21.2021
Urien, Louise, and Bauer, Elizabeth P. "Sex Differences in BNST and Amygdala Activation by Contextual, Cued, and Unpredictable Threats." eNeuro vol. 9,1 (2022). doi: https://doi.org/10.1523/ENEURO.0233-21.2021
Urien L, Bauer EP. Sex Differences in BNST and Amygdala Activation by Contextual, Cued, and Unpredictable Threats. eNeuro. 2022 Jan 06;9(1). doi: 10.1523/ENEURO.0233-21.2021. Print 2022. PMID: 34911788.
Copy Download .nbib Format: NLM
Design and Implementation of Intelligent Agent Training Systems for Virtual Vehicles.

Sensors (Basel, Switzerland)

Urrea C, Garrido F, Kern J.
PMID: 33445582
Sensors (Basel). 2021 Jan 12;21(2). doi: 10.3390/s21020492.

This paper presents the results of the design, simulation, and implementation of a virtual vehicle. Such a process employs the Unity videogame platform and its Machine Learning-Agents library. The virtual vehicle is implemented in Unity considering mechanisms that represent...

Cite
Urrea C, Garrido F, Kern J. Design and Implementation of Intelligent Agent Training Systems for Virtual Vehicles. Sensors (Basel). 2021;21(2)doi: 10.3390/s21020492.
Urrea, C., Garrido, F., & Kern, J. (2021). Design and Implementation of Intelligent Agent Training Systems for Virtual Vehicles. Sensors (Basel, Switzerland), 21(2), . https://doi.org/10.3390/s21020492
Urrea, Claudio, et al. "Design and Implementation of Intelligent Agent Training Systems for Virtual Vehicles." Sensors (Basel, Switzerland) vol. 21,2 (2021). doi: https://doi.org/10.3390/s21020492
Urrea C, Garrido F, Kern J. Design and Implementation of Intelligent Agent Training Systems for Virtual Vehicles. Sensors (Basel). 2021 Jan 12;21(2). doi: 10.3390/s21020492. PMID: 33445582; PMCID: PMC7827925.
Copy Download .nbib Format: NLM
Anterior-segment imaging for assessment of glaucoma.

Expert review of ophthalmology

Ursea R, Silverman RH.
PMID: 20305726
Expert Rev Ophthalmol. 2010 Feb 01;5(1):59-74. doi: 10.1586/eop.09.61.

This article summarizes the physics, technology and clinical application of ultrasound biomicroscopy (UBM) and optical coherence tomography (OCT) for assessment of the anterior segment in glaucoma. UBM systems use frequencies ranging from approximately 35 to 80 MHz, as compared...

Cite
Ursea R, Silverman RH. Anterior-segment imaging for assessment of glaucoma. Expert Rev Ophthalmol. 2010;5(1):59-74doi: 10.1586/eop.09.61.
Ursea, R., & Silverman, R. H. (2010). Anterior-segment imaging for assessment of glaucoma. Expert review of ophthalmology, 5(1), 59-74. https://doi.org/10.1586/eop.09.61
Ursea, Roxana, and Silverman, Ronald H. "Anterior-segment imaging for assessment of glaucoma." Expert review of ophthalmology vol. 5,1 (2010): 59-74. doi: https://doi.org/10.1586/eop.09.61
Ursea R, Silverman RH. Anterior-segment imaging for assessment of glaucoma. Expert Rev Ophthalmol. 2010 Feb 01;5(1):59-74. doi: 10.1586/eop.09.61. PMID: 20305726; PMCID: PMC2839239.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 77 entries